Clinical Trials in Chicago

Showing 3581-3600 of 17,609 trials

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

NCT05808634

The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma

BioAtla, Inc.168 participantsStarted Jul 2023

Irvine, California, United States • Los Angeles, California, United States • New Haven, Connecticut, United States +6 more locations

WITHDRAWNPhase 1/22.2 miles

Gene Therapy for the Treatment of Chronic Stable Angina

NCT01002495

The purpose of this study is to evaluate the safety and tolerability of catheter based injections of VM202 into the heart.

Myocardial Ischemia

Helixmith Co., Ltd.Started Mar 2015

Chicago, Illinois, United States • Minneapolis, Minnesota, United States

Active Not RecruitingPhase 32.2 miles

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

NCT03690388

The objective of this study is to evaluate the effect of cabozantinib compared with placebo on progression free survival (PFS) and objective response rate (ORR) in subjects with Radioiodine-Refractory Differentiated Thyroid Cancer (DTC) who have progressed after prior vascular endothelial growth factor receptor (VEGFR)-Targeted therapy.

Differentiated Thyroid Cancer

Exelixis187 participantsStarted Oct 2018

Newport Beach, California, United States • Sacramento, California, United States • San Francisco, California, United States +161 more locations

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Gene Therapy for the Treatment of Chronic Stable Angina

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

Find Trials by Condition in Chicago

The Course of Hip Flexion Weakness Following LLIF or ALIF

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis

A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)

A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery

A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium

ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

A Study to Evaluate ELX/TEZ/IVA on Cough and Physical Activity in Participants With Cystic Fibrosis (CF)